New Funding Model
The new funding model (NFM) is the crucial opportunity to determine the speed with which countries are able to expand and innovate in their responses to the three diseases and to make up for delays in the scale-up of programs that has been stalled since the cancellation of Round 11.
On 12 October 2012, the Global Fund Secretariat submitted a paper containing options and recommendations for the design of the new funding model to the Strategy, Investment and Impact Committee (SIIC) of the Global Fund Board. The SIIC will discuss the paper at its meeting in Geneva of 24–26 October 2012.
At the recent Global Fund Board meeting, considerable discussion and energy was devoted to the design of the new funding model (NFM), particularly concerning the issue of how funding would be allocated. The discussions took place during the pre-meeting (12 September) and on both days of the Board meeting itself (13 and 14). Almost 12 hours had been set aside, and were taken, to discuss the new model.
Editor’s Note: This explanation of the broad elements of the new funding model is based on the decision point adopted by the Board. Not everything in the decision point is clear, so this explanation includes some interpretation by Aidspan. Readers are advised to check with the Global Fund Secretariat if they have questions.
Editor’s Note: Included in this summary is the Board decision on the broad elements of the new funding model.
Twelve civil society organisations (CSOs), most of them from Eastern Europe and Central Asia, have submitted a joint position paper on the development of a new funding model for the Global Fund.
Concerns have been raised by civil society organisations (CSOs) about the process being followed to develop a new funding model for the Global Fund, and about the fact that most of the discussions have focused on formulas for allocating funding.
Activists disrupt session at AIDS 2012 on the future of the Global Fund
Jaramillo signs pledge to oppose the use of funding caps
The Global Fund Board has decided to implement a new funding architecture in order to simplify processes for grant implementers. The centrepiece is the concept of a "single stream of funding" per PR per disease.